Tissue of Origin: Head-and-Neck Cancer
Cancer Type: Head-and-Neck Squamous Cell Carcinoma
MSK-921 is a human head-and-neck cancer cell line.
This cell line was established from a subject with head-and-neck squamous cell carcinoma.
- Peter G. Sacks, MD, former Associate Attending, Surgery, Memorial Hospital, Memorial Sloan Kettering Cancer Center
PubMed=7927946; DOI=10.1002/ijc.2910590316 Xu L., Davidson B.J., Murty V.V.V.S., Li R.-G., Sacks P.G., Garin-Chesa P., Schantz S.P., Chaganti R.S.K. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer 59:383-387(1994)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at [email protected].
For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354, [email protected].